BridgeBio Pharma plans to offer $500 million in convertible senior notes, aiming to strengthen its financial position and reduce interest expenses. BridgeBio Pharma, Inc. announced plans to offer $500 ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Alnylam Pharma ( (ALNY)) has provided an ...
BridgeBio Pharma, Inc. has announced the pricing of $500 million in convertible senior notes at a 1.75% interest rate, maturing in 2031, in a private offering aimed at qualified institutional buyers.
GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on ...
In the realm of biotech and pharmaceuticals, fundraising often plays a pivotal role in driving innovation and progress. Biotech and pharmaceutical companies, whether private startups or established ...
STOUGHTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) (the “Company”), a leading, diversified specialty pharmaceutical company committed to improving the ...
The Royalty Pharma PLC-Bond has a maturity date of 9/25/2055 and offers a coupon of 5.9500%. The payment of the coupon will take place 2,0 times per biannual on the 25.03.. The Royalty Pharma PLC-Bond ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results